So yes the environment at least for the next few quarters will remain slightly challenging and I think it will therefore lead to maybe a little bit of a lowering of expectations from a return perspective especially in light of the fact that we are coming out of very strong last three years post-COVID.
Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?
Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth in revenue.